selected publications
- Flow cytometry-assisted quantification of cell cycle arrest in cancer cells treated with CDK4/6 inhibitors. Methods in cell biology. 2023 Academic Article GET IT
- Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors. Journal of translational medicine. 2023 Academic Article GET IT
- Quantification of beta-galactosidase activity as a marker of radiation-driven cellular senescence. Methods in cell biology. 2022 Academic Article GET IT
- Quantitative assessment of mitophagy in irradiated cancer cells. Methods in cell biology. 2022 Academic Article GET IT
- Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysis. 2022 GET IT
- RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells. 2022 GET IT
- Cytofluorometric assessment of acute cell death responses driven by radiation therapy. 2022 GET IT
- Nicotinamide drives T cell activation in the mammary tumor microenvironment. Journal of translational medicine. 2022 Letter GET IT
- Cytofluorometric assessment of cell cycle progression in irradiated cells. 2022 GET IT
-
Metabolic features of cancer cells impact immunosurveillance.
Journal for immunotherapy of cancer.
2021
Academic Article
GET IT
Times cited: 12 - Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells. STAR protocols. 2021 Academic Article GET IT
-
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2021
Academic Article
GET IT
Times cited: 41 -
Autophagy-mediated metabolic effects of aspirin.
Cell death discovery.
2020
Academic Article
GET IT
Times cited: 16 -
MPA/DMBA-driven mammary carcinomas.
Methods in cell biology.
2020
Article
GET IT
Times cited: 1 -
NK cells beat T cells at early breast cancer control.
Oncoimmunology.
2020
Editorial Article
GET IT
Times cited: 11 -
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.
Nature immunology.
2020
Academic Article
GET IT
Times cited: 48 -
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.
Nature communications.
2020
Academic Article
GET IT
Times cited: 74 -
Possible mechanisms of cancer prevention by nicotinamide.
British journal of pharmacology.
2020
Information Resource
GET IT
Times cited: 3 -
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients.
Oncoimmunology.
2019
Academic Article
GET IT
Times cited: 98 - Monitoring abscopal responses to radiation in mice. Methods in enzymology. 2019 Article GET IT
-
Metabolic enzymes expressed by cancer cells impact the immune infiltrate.
Oncoimmunology.
2019
Academic Article
GET IT
Times cited: 13 -
Immune effectors responsible for the elimination of hyperploid cancer cells.
Oncoimmunology.
2018
Academic Article
GET IT
Times cited: 14 -
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance.
Immunological reviews.
2017
Information Resource
GET IT
Times cited: 47 -
Image Cytofluorometry for the Quantification of Ploidy and Endoplasmic Reticulum Stress in Cancer Cells.
Methods in molecular biology (Clifton, N.J.).
2017
Article
GET IT
Times cited: 7 - The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ. Oncoimmunology. 2016 Academic Article GET IT
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 2016 Information Resource GET IT
-
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance.
Cancer cell.
2016
Academic Article
GET IT
Times cited: 382 -
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.
Oncoimmunology.
2016
Information Resource
GET IT
Times cited: 49 -
Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer.
Oncoimmunology.
2016
Academic Article
GET IT
Times cited: 19 - Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology. 2015 Information Resource GET IT
- Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology. 2015 Information Resource GET IT
-
Morphometric analysis of immunoselection against hyperploid cancer cells.
Oncotarget.
2015
Academic Article
GET IT
Times cited: 11 - Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology. 2015 Information Resource GET IT
- Trial Watch: Adoptive cell transfer for oncological indications. Oncoimmunology. 2015 Information Resource GET IT
- Trial watch: Naked and vectored DNA-based anticancer vaccines. Oncoimmunology. 2015 Academic Article GET IT
-
eIF2α phosphorylation as a biomarker of immunogenic cell death.
Seminars in cancer biology.
2015
Information Resource
GET IT
Times cited: 69 - Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology. 2015 Information Resource GET IT
- Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. Oncoimmunology. 2015 Information Resource GET IT
- Trial Watch: Peptide-based anticancer vaccines. Oncoimmunology. 2015 Information Resource GET IT
-
Classification of current anticancer immunotherapies.
Oncotarget.
2014
Review
GET IT
Times cited: 368 - Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology. 2014 Information Resource GET IT
- Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014 Information Resource GET IT
- Trial Watch: Radioimmunotherapy for oncological indications. Oncoimmunology. 2014 Information Resource GET IT
- Vitamin B6 improves the immunogenicity of cisplatin-induced cell death. Oncoimmunology. 2014 Academic Article GET IT
-
Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer.
Oncogene.
2014
Academic Article
GET IT
Times cited: 50 - Trial Watch:: Oncolytic viruses for cancer therapy. Oncoimmunology. 2014 Information Resource GET IT
- Trial Watch: DNA vaccines for cancer therapy. Oncoimmunology. 2014 Information Resource GET IT